On September 7, 2021, China Resources Pharmaceutical (03320.HK) announced that with effect from 7 September 2021, Li Xiangming will no longer serve as an executive director, vice chairman and member of the executive committee of the Company; Yu Zhongliang will no longer serve as a non-executive director of the company; Guo Wei will no longer serve as a non-executive director, member of the audit committee and member of the remuneration committee of the company; Tao Ran will be appointed as an executive director and executive committee member of the company; and Lin Guolong will be appointed as a non-executive director, a member of the audit committee and a member of the remuneration committee of the company And Tan Ying was appointed as a non-executive Director of the Company.
This article originated from Grand Gateway
![Yan Qi, member of the National Committee of the Chinese People's Political Consultative Conference and founder of Chongqing Taoranju: Support private enterprises to participate in rural revitalization[fig]](data:image/gif;base64,R0lGODlhAQABAIAAAP///wAAACwAAAAAAQABAAACAkQBADs=)